|
?:abstract
|
-
SARS-COV-2 is a beta-coronavirus and was first reported in December 2019 in Wuhan, China and the first reported case of neonatal COVID-19 was in february 2020, concerns have been raised about possible transmission of SARS-CoV-2 and its severity, but information on newborns with confirmed or suspected COVID-19 is still limited;its presentation has been reported to be more common as a mild or asymptomatic disease compared to adults The newborn can become infected after birth, either from his mother, family member or within the hospital environment through droplets from the respiratory tract infected fomites and through the air during aerosolization procedures Diagnosis requires detection of the sequence RT-PCR virus homologue of SAR-CoV-2 from the upper respiratory tract (nasopharyngeal or oropharyngeal swab), lower respiratory tract (sputum, endotracheal aspirate or bronchoalveolar lavage) or blood (serum) The neonatal intensive care unit (NICU) objectives for these patients is preventing, controling and establishing measures to ensure the adequate management of these patients who can potentially become infected Medical and respiratory management is not yet clear and there are several proposals in studies worldwide But these recommendations for the care of newborns of mothers with confirmed or suspected COVID-19 are specific and can be modified by the limitations of the infrastructure and the availability of protective equipment in each hospital center
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}